How much did Arvinas achieve in EBIT for the current year?
In the current year, Arvinas has achieved an EBIT of -338.46 M USD.
Arvinas EBIT 2024
Arvinas EBIT
-338.46 M USD
Ticker
ARVN
ISIN
US04335A1051
WKN
A2N6VP
In 2024, Arvinas's EBIT was -338.46 M USD, a -15.7% increase from the -401.5 M USD EBIT recorded in the previous year.
The Arvinas EBIT history
| YEAR | EBIT (undefined USD) |
|---|---|
| 2029e | - |
| 2028e | 48.67 |
| 2027e | -204.25 |
| 2026e | -341.6 |
| 2025e | -357.89 |
| 2024e | -338.46 |
| 2023 | -401.5 |
| 2022 | -263.2 |
| 2021 | -195.3 |
| 2020 | -124.9 |
| 2019 | -51.5 |
| 2018 | -43.8 |
| 2017 | -24.8 |
| 2016 | -16.5 |
Arvinas Revenue, EBIT, Net Income US04335A1051 · A2N6VP
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Arvinas, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Arvinas from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Arvinas’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Arvinas. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Arvinas’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Arvinas’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Arvinas’s growth potential.
Arvinas Revenue, EBIT and net profit per share
| Date | Arvinas Revenue | Arvinas EBIT | Arvinas Net Income |
|---|---|---|---|
| 2029e | 1 B undefined | 0 undefined | 179.61 M undefined |
| 2028e | 711.74 M undefined | 48.67 M undefined | 62.55 M undefined |
| 2027e | 473.06 M undefined | -204.25 M undefined | -122.14 M undefined |
| 2026e | 251.56 M undefined | -341.6 M undefined | -303.06 M undefined |
| 2025e | 201.85 M undefined | -357.89 M undefined | -324.12 M undefined |
| 2024e | 219.4 M undefined | -338.46 M undefined | -245.65 M undefined |
| 2023 | 78.5 M undefined | -401.5 M undefined | -367.3 M undefined |
| 2022 | 131.4 M undefined | -263.2 M undefined | -282.5 M undefined |
| 2021 | 46.7 M undefined | -195.3 M undefined | -191 M undefined |
| 2020 | 21.8 M undefined | -124.9 M undefined | -119.3 M undefined |
| 2019 | 43 M undefined | -51.5 M undefined | -70.3 M undefined |
| 2018 | 14.3 M undefined | -43.8 M undefined | -239.8 M undefined |
| 2017 | 7.6 M undefined | -24.8 M undefined | -28.6 M undefined |
| 2016 | 6.7 M undefined | -16.5 M undefined | -12.4 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2016 | 6.7 M USD | -16.5 M USD | -12.4 M USD |
| 2017 | 7.6 M USD | -24.8 M USD | -28.6 M USD |
| 2018 | 14.3 M USD | -43.8 M USD | -239.8 M USD |
| 2019 | 43 M USD | -51.5 M USD | -70.3 M USD |
| 2020 | 21.8 M USD | -124.9 M USD | -119.3 M USD |
| 2021 | 46.7 M USD | -195.3 M USD | -191 M USD |
| 2022 | 131.4 M USD | -263.2 M USD | -282.5 M USD |
| 2023 | 78.5 M USD | -401.5 M USD | -367.3 M USD |
| 2024e | 219.4 M USD | -338.46 M USD | -245.65 M USD |
| 2025e | 201.85 M USD | -357.89 M USD | -324.12 M USD |
| 2026e | 251.56 M USD | -341.6 M USD | -303.06 M USD |
| 2027e | 473.06 M USD | -204.25 M USD | -122.14 M USD |
| 2028e | 711.74 M USD | 48.67 M USD | 62.55 M USD |
| 2029e | 1 B USD | 0 USD | 179.61 M USD |
Arvinas stock margins US04335A1051 · A2N6VP
The Arvinas margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Arvinas. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Arvinas.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Arvinas's sales revenue. A higher gross margin percentage indicates that the Arvinas retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Arvinas's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Arvinas's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Arvinas's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Arvinas. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Arvinas's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Arvinas Margin History
| Arvinas Gross margin | Arvinas Profit margin | Arvinas EBIT margin | Arvinas Profit margin |
|---|---|---|---|
| 2029e | 0 % | 0 % | 17.93 % |
| 2028e | 0 % | 6.84 % | 8.79 % |
| 2027e | 0 % | -43.18 % | -25.82 % |
| 2026e | 0 % | -135.79 % | -120.47 % |
| 2025e | 0 % | -177.31 % | -160.57 % |
| 2024e | 0 % | -154.27 % | -111.96 % |
| 2023 | 0 % | -511.47 % | -467.9 % |
| 2022 | 0 % | -200.3 % | -214.99 % |
| 2021 | 0 % | -418.2 % | -408.99 % |
| 2020 | 0 % | -572.94 % | -547.25 % |
| 2019 | 0 % | -119.77 % | -163.49 % |
| 2018 | 0 % | -306.29 % | -1,676.92 % |
| 2017 | 0 % | -326.32 % | -376.32 % |
| 2016 | 0 % | -246.27 % | -185.07 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2016 | 0 % | -246.27 % | -185.07 % |
| 2017 | 0 % | -326.32 % | -376.32 % |
| 2018 | 0 % | -306.29 % | -1,676.92 % |
| 2019 | 0 % | -119.77 % | -163.49 % |
| 2020 | 0 % | -572.94 % | -547.25 % |
| 2021 | 0 % | -418.2 % | -408.99 % |
| 2022 | 0 % | -200.3 % | -214.99 % |
| 2023 | 0 % | -511.47 % | -467.9 % |
| 2024e | 0 % | -154.27 % | -111.96 % |
| 2025e | 0 % | -177.31 % | -160.57 % |
| 2026e | 0 % | -135.79 % | -120.47 % |
| 2027e | 0 % | -43.18 % | -25.82 % |
| 2028e | 0 % | 6.84 % | 8.79 % |
| 2029e | 0 % | 0 % | 17.93 % |
Arvinas Aktienanalyse
What does Arvinas do?
Arvinas Inc. is a biopharmaceutical company based in New Haven, Connecticut, USA. It was founded in 2013 by Dr. Craig Crews, who also serves as a scientific advisor to the company. The company's mission is to develop innovative therapies based on Proteolysis-Targeting Technology (PROTAC). This technology uses artificially engineered molecules to identify and mark specific proteins in the body, which are then degraded by the body's own enzymes. This approach can treat diseases caused by misfolded or overexpressed proteins. Arvinas' business model is to develop multiple drug candidates based on this platform. The company collaborates with leading academic institutions and biotechnology companies to identify targets that can be reached using PROTAC technology. Additionally, the company has a proprietary pipeline of drug candidates in various stages of clinical development. Arvinas operates in several therapeutic areas, including cancer, immunology, and metabolic disorders. Their drug candidates include ARV-110, a PROTAC targeting the androgen receptor protein (AR), which is a potential therapy for patients with resistant prostate cancer. Similarly, Arvinas' other drug candidates target specific proteins associated with certain diseases. Another drug from the company is ARV-471, an orally administered degrader targeting the estrogen receptor alpha (ERa), which plays a role in breast cancer. ARV-471 is a potential therapy for patients with rare subtypes of breast cancer. Arvinas also has partnerships in various areas of drug development. For example, in collaboration with Pfizer, they are developing ARV-411, a PROTAC targeting the menin-1 protein, which is involved in acute myeloid leukemia. Arvinas also has a partnership with Genentech, a subsidiary of Roche, for the use of PROTAC in the treatment of cancer. Overall, Arvinas is an innovative biopharmaceutical company based on Proteolysis-Targeting Technology, focusing on the development of comprehensive therapeutic approaches. With numerous partnerships and a diverse pipeline, the company is well-positioned to play a significant role in drug development. Arvinas ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Arvinas's EBIT
Arvinas's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Arvinas's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Arvinas's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Arvinas’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Arvinas stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Arvinas.
How has the EBIT of Arvinas developed in recent years?
The EBIT of Arvinas has increased by -15.701% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Arvinas?
The EBIT of Arvinas is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Arvinas pay?
Over the past 12 months, Arvinas paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arvinas is expected to pay a dividend of 0 USD.
What is the dividend yield of Arvinas?
The current dividend yield of Arvinas is .
When does Arvinas pay dividends?
Arvinas pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Arvinas?
Arvinas paid dividends every year for the past 0 years.
What is the dividend of Arvinas?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Arvinas located?
Arvinas is assigned to the 'Health' sector.
Wann musste ich die Aktien von Arvinas kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Arvinas from 10/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.
When did Arvinas pay the last dividend?
The last dividend was paid out on 10/4/2024.
What was the dividend of Arvinas in the year 2023?
In the year 2023, Arvinas distributed 0 USD as dividends.
In which currency does Arvinas pay out the dividend?
The dividends of Arvinas are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Arvinas
Our stock analysis for Arvinas Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arvinas Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
